ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Simplified Herbal Formula Improves Cardiac Function and Reduces Inflammation in Mice Through the TLR-Mediated NF-κB Signaling Pathway

Dong, Xiaoming; Han, Xiaowei; Zhang, Xiaojiao; Li, Sijing; Li, Ziru; Kang, Jinhua; Jiang, Jialin; Ni, Shihao; Lu, Lu; He, Zhiling; Huang, Haoming; Xian, Shaoxiang; Yuan, Tianhui; Yang, Zhongqi*; Long, Wenjie*; Wan, Zemin*广州中医药大学; 1
Frontiers in Pharmacology2022-6-6DOI: 10.3389/fphar.2022.865614
1被引7阅读
引用收藏
分享

摘要

Nuanxinkang tablet (NXK), a Chinese herbal formula, can improve heart function and quality of life in patients with chronic heart failure (CHF). However, the mechanisms of action of NXK are not fully understood. In this study, we investigated the effects of NXK on inflammation in the CHF mouse model. This model was established by transverse aortic constriction (TAC) and treated with NXK for 8 weeks. Then, the cardiac function and myocardial fibrosis were evaluated. The monocytes/macrophages were evaluated by immunofluorescence. The mRNA levels of IL-1 beta, IL-6, TNF-alpha, ICAM-1, and VCAM-1 were measured by quantitative real-time polymerase chain reaction (qRT-PCR), while TLR4, MyD88, NF-kappa B p65, P-I kappa B alpha, TLR2, TLR7 and TLR9 protein levels were evaluated by Western blot. The results showed that NXK improved the left ventricular ejection fraction (LVEF) and left ventricular end-systolic dimension, reversed myocardial fibrosis, and inhibited pro-inflammatory (CD11b + Ly6C+) monocytes/macrophages in the TAC mouse model. NXK also reduced the mRNA and protein levels of the above markers. Taken together, NXK improved heart function and reduced inflammation through the TLR-mediated NF-kappa B signaling pathway, suggesting that it might be used as an innovative treatment strategy for CHF.

学科与关键词

关键词
chronic heart failureinflammationChinese medicineNuanxinkang tabletTLR-mediated NF-kappa B signaling pathway
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-06-06
卷期
第 13 卷
页码
865614
DOI
10.3389/fphar.2022.865614
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Clinical Research Base of Traditional Chinese Medicine [2018)131 (2110100606)]; Scientific Research Project of Guangdong Provincial Bureau of Traditional Chinese Medicine [20212061]; Guangdong Province Basic and Applied Research Fund Project [2020A1515110520]; Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine [ZY2022YL23]; Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine [BJ2022KY04]

作者

  • D

    Dong, Xiaoming (第一作者)

    1 · guangzhou univ chinese med

  • H

    Han, Xiaowei

    1 · guangzhou univ chinese med

查看全部 16 位作者收起作者
  • Z

    Zhang, Xiaojiao

    1 · guangzhou univ chinese med

  • L

    Li, Sijing

    1 · guangzhou univ chinese med

  • L

    Li, Ziru

    1 · guangzhou univ chinese med

  • K

    Kang, Jinhua

    1 · guangzhou univ chinese med

  • J

    Jiang, Jialin

    1 · guangzhou univ chinese med

  • N

    Ni, Shihao

    1 · guangzhou univ chinese med

  • L

    Lu, Lu

    guangzhou univ chinese med

  • H

    He, Zhiling

    2 · guangzhou univ chinese med

  • H

    Huang, Haoming

    1 · guangzhou univ chinese med

  • X

    Xian, Shaoxiang

    1 · guangzhou univ chinese med

  • Y

    Yuan, Tianhui

    1 · guangzhou univ chinese med

  • Y

    Yang, Zhongqi (通讯)

    guangzhou univ chinese med · 1

  • L

    Long, Wenjie (通讯)

    guangzhou univ chinese med · 1

  • W

    Wan, Zemin (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417